器官移植供体大约半数来自于创伤性脑损伤及继发脑死亡(BD)患者,而其中只有33%的心脏适于移植。脑死亡后多种病理改变能导致心功能障碍而不适于移植。为了减少脑死亡相关的心功能障碍,目前措施是应用甲基泼尼松龙、甲状腺激素及抗利尿激素联合复苏法,但临床效果存在争议。最近 Approximately half of organ transplant donors come from patients with traumatic brain injury and secondary brain death (BD), of whom only 33% of the heart are transplantable. A variety of pathological changes after brain death can lead to cardiac dysfunction and not suitable for transplantation. In order to reduce cardiac death associated with brain dysfunction, the current measures are the application of methylprednisolone, thyroid hormone and antidiuretic hormone combined with resuscitation, but the clinical effect is controversial. recent